lipoxygenase products
Recently Published Documents


TOTAL DOCUMENTS

328
(FIVE YEARS 3)

H-INDEX

45
(FIVE YEARS 1)

2021 ◽  
pp. 114825
Author(s):  
Christian Kretzer ◽  
Paul M. Jordan ◽  
Katharina P.L. Meyer ◽  
Daniel Hoff ◽  
Markus Werner ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Theresa Ramalho ◽  
Luciano Filgueiras ◽  
Ildefonso Alves Silva-Jr ◽  
Ana Flavia Marçal Pessoa ◽  
Sonia Jancar

Author(s):  
Giuliana d'Ippolito ◽  
Genoveffa Nuzzo ◽  
Angela Sardo ◽  
Emiliano Manzo ◽  
Carmela Gallo ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Carla da S. Pinheiro ◽  
Ana Paula T. Monteiro ◽  
Fabiano F. Dutra ◽  
Marcelo T. Bozza ◽  
Marc Peters-Golden ◽  
...  

TLRs recognize a broad spectrum of microorganism molecules, triggering a variety of cellular responses. Among them, phagocytosis is a critical process for host defense. Leukotrienes (LTs), lipid mediators produced from 5-lipoxygenase (5-LO) enzyme, increase FcγR-mediated phagocytosis. Here, we evaluated the participation of TLR2, TLR3, TLR4, and TLR9 in FcγR-mediated phagocytosis and whether this process is modulated by LTs. Rat alveolar macrophages (AMs), murine bone marrow-derived macrophages (BMDMs), and peritoneal macrophages (PMs) treated with TLR2, TLR3, and TLR4 agonists, but not TLR9, enhanced IgG-opsonized sheep red blood cell (IgG-sRBC) phagocytosis. Pretreatment of AMs or BMDMs with drugs that block LT synthesis impaired the phagocytosis promoted by TLR ligands, and TLR potentiation was also abrogated in PMs and BMDMs from 5-LO−/−mice. LTB4production induced by IgG engagement was amplified by TLR ligands, while cys-LTs were amplified by activation of TLR2 and TLR4, but not by TLR3. We also noted higher ERK1/2 phosphorylation in IgG-RBC-challenged cells when preincubated with TLR agonists. Furthermore, ERK1/2 inhibition by PD98059 reduced the phagocytic activity evoked by TLR agonists. Together, these data indicate that TLR2, TLR3, and TLR4 ligands, but not TLR9, amplify IgG-mediated phagocytosis by a mechanism which requires LT production and ERK-1/2 pathway activation.


2015 ◽  
Vol 93 (9) ◽  
pp. 787-791 ◽  
Author(s):  
Zsófia Mezei ◽  
Omid Zamani-Forooshani ◽  
Krisztina Csabafi ◽  
Bence Szikszai ◽  
Eszter Papp ◽  
...  

Kisspeptin has been implicated in cardiovascular control. Eicosanoids play a crucial role in the activation of platelets and the regulation of vascular tone. In the present study, we investigated the effect of kisspeptins on eicosanoid synthesis in platelets and aorta in vitro. Platelets and aorta were isolated from Wistar–Kyoto rats. After preincubation with different doses of kisspeptin, samples were incubated with [1-14C]arachidonic acid (0.172 pmol/mL) in tissue culture Medium 199. The amount of labeled eicosanoids was measured with liquid scintillation, after separation with overpressure thin-layer chromatography. Kisspeptin-13 stimulated the thromboxane synthesis. The dose–response curve was bell-shaped and the most effective concentration was 2.5 × 10−8 mol/L, inducing a 27% increase. Lipoxygenase products of platelets displayed a dose-dependent elevation up to the dose of 5 × 10−8 mol/L. In the aorta, kisspeptin-13 induced a marked elevation in the production of 6-keto-prostaglandin F1α, the stable metabolite of prostacyclin, and lipoxygenase products. Different effects of kisspeptin on cyclooxygenase and lipoxygenase products indicate that beyond intracellular Ca2+ mobilization, other signaling pathways might also contribute to its actions. Our data suggest that kisspeptin, through the alteration of eicosanoid synthesis in platelets and aorta, may play a physiologic and (or) pathologic role in the regulation of vascular tone.


Sign in / Sign up

Export Citation Format

Share Document